<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Neurociencias.artículos</title>
<link>https://repositorio.fleni.org.ar/xmlui/handle/123456789/50</link>
<description/>
<pubDate>Tue, 07 Jul 2026 03:12:40 GMT</pubDate>
<dc:date>2026-07-07T03:12:40Z</dc:date>
<item>
<title>Nucleoli-localized KANSL2 as an epigenetic regulator of ribosome biogenesis in glioblastoma cells</title>
<link>https://repositorio.fleni.org.ar/xmlui/handle/123456789/1521</link>
<description>Nucleoli-localized KANSL2 as an epigenetic regulator of ribosome biogenesis in glioblastoma cells
Budnik, Nicolás; Canedo, Lucía; Morellato, Agustín E.; Cuenca, Marina B.; Garmendia, Martina; Senin, Sergio; Romano, Sebastián A.; Andrysik, Zdenek; Videla Richardson, Guillermo Agustín; Graner, Michael W.; Kobayashi, Ken; Zhou, Yilong; Wiese, Meike; Akhtar, Asifa; Espinosa, Joaquín M.; Perez-Castro, Carolina
KANSL2 is a subunit of the non-specific lethal (NSL) chromatin-modifying complex associated with glioblastoma (GBM) progression, but the intrinsic role of KANSL2 in GBM cells is poorly understood. By analyzing TCGA-GBM and GTEx datasets, we found that KANSL2 is upregulated in GBM and positively correlates with genes involved in ribosome biogenesis. Immunofluorescence and cell cycle analyses reveal a dynamic nuclear distribution, with KANSL2 becoming enriched in nucleoli mainly during G1/early S and G2 phases. Overexpression of KANSL2 increases 45S pre-rRNA and 28S rRNA levels, whereas its silencing reduces rRNA expression and histone H4 acetylation at lysines 5 and 8 within rDNA promoters. RNA-seq of patient-derived GBM spheroids confirms a global downregulation of ribosome biogenesis genes upon silencing of KANSL2. Together, these findings identify KANSL2 as a nuclear factor that transiently associates with nucleoli to promote rRNA transcription and ribosome biogenesis, supporting the biosynthetic and proliferative capacity of glioblastoma cells.
</description>
<pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repositorio.fleni.org.ar/xmlui/handle/123456789/1521</guid>
<dc:date>2026-03-05T00:00:00Z</dc:date>
</item>
<item>
<title>Persistent memory in network topologies following temporary stimuli</title>
<link>https://repositorio.fleni.org.ar/xmlui/handle/123456789/1498</link>
<description>Persistent memory in network topologies following temporary stimuli
Sevlever, Federico; Waisman, Ariel; Miriuka, Santiago; Ventura, Alejandra C.
Molecular memory in signaling and gene regulatory networks shapes how cells respond to transient inputs. Here, we present a mathematical framework to quantify memory as changes in system state after temporary stimulation. Using computational models, we show that circuits with positive feedback loops, particularly those enabling bistability, sustain long-term memory, while certain negative feedbacks can erase it. We further identify minimal network motifs that reliably confer memory, revealing symmetry between activating and inactivating mechanisms. In addition, oscillatory circuits can encode memory even without positive feedback, storing information in the phase of their oscillations. Applying this approach to mouse embryonic stem cells exposed to transient differentiation cues, we find that different genes display distinct degrees of memory retention, with some reflecting partial reversion and others indicating commitment to differentiation. This framework provides a unified way to compare memory across systems and highlights how circuit architecture influences information storage in biology.
</description>
<pubDate>Fri, 21 Nov 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repositorio.fleni.org.ar/xmlui/handle/123456789/1498</guid>
<dc:date>2025-11-21T00:00:00Z</dc:date>
</item>
<item>
<title>Novel in-frame variant in DES (p.Glu353dup) causes myofibrillar myopathy: clinical, in silico and functional studies</title>
<link>https://repositorio.fleni.org.ar/xmlui/handle/123456789/1492</link>
<description>Novel in-frame variant in DES (p.Glu353dup) causes myofibrillar myopathy: clinical, in silico and functional studies
Castañeda, Sheila; Amín, Guadalupe; Freiberger, María Inés; Zabalegui, Federico; Renes, Sol; Fernández Gamba, Ágata; Rosa, Alberto Luis; Cejas, Claudia Patricia; Pastor Rueda, José Manuel; Waisman, Ariel; Ferreiro, Diego; Sevlever, Gustavo Emilio; Miriuka, Santiago; Moro, Lucía Natalia
Background: Desmin (DES) is a major intermediate filament protein involved in the structural integrity and function of striated muscles. Pathogenic mutations in DES are predominantly missense variants, causing isolated cardiomyopathy and combinations of myopathy and cardiomyopathy. In-frame insertions are very rare and usually classified as variants of uncertain significance or likely pathogenic due to limited predictive and/or experimental evidence.&#13;
&#13;
Methods: This study describes a novel heterozygous in-frame insertion in exon 6 of DES (RefSeq NM_001927.4:c.1059_1061dup) identified in an Argentine family with myofibrillar myopathy (MFM). This mutation results in the duplication of a glutamic acid residue at position 353 (NP_001918.3:p.(Glu353dup)), in the 2B subdomain of the central rod domain. Clinical, computational and functional analyses were performed to study the pathogenicity of this variant.&#13;
&#13;
Results: Clinically, the index patient exhibited hallmark MFM features, including progressive muscle weakness, atrophy and fatty muscle replacement. In silico analyses of molecular dynamics revealed that p.Glu353dup alters DES dimer assembly by stabilising an aberrant coiled-coil conformation, a mechanism not previously proposed for DES mutations. Functional studies in HEK293T cells and C2C12 myocytes suggested that the p.Glu353dup variant induces aberrant DES aggregation, confirming its detrimental effect on filament organisation.&#13;
&#13;
Conclusion: These findings are consistent with the idea that p.Glu353dup is a pathogenic variant, supported by clinical studies, in silico protein modelling and functional evidence, highlighting the impact of in-frame insertions on DES filament homeostasis. By providing computational and experimental evidence, this study expands our understanding of desminopathies and offers new perspectives for pathogenicity assessment of uncertain DES variants.
</description>
<pubDate>Wed, 31 Dec 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repositorio.fleni.org.ar/xmlui/handle/123456789/1492</guid>
<dc:date>2025-12-31T00:00:00Z</dc:date>
</item>
<item>
<title>Capacity building in dementia research: insights from the World Young Leaders in Dementia</title>
<link>https://repositorio.fleni.org.ar/xmlui/handle/123456789/1484</link>
<description>Capacity building in dementia research: insights from the World Young Leaders in Dementia
Morello-García, Florentina; Corvalán, Nicolás; Llibre-Guerra, Jorge; Arruabarrena, Micaela; Clarens, María Florencia; Keller, Greta; De Los Santos, Loana; Martin, María Eugenia; Schaffer Aguzzoli, Cristiano; Allegri, Ricardo Francisco; Amaral, Livia; Ardohain Cristalli, Carolina; Bellaver, Bruna; Ngozi Best, Merci; Bloomquist, Madeleine; Chen, Kevin; Surace, Ezequiel Ignacio; Wilks, Hannah; Zimmer, Eduardo; Crivelli, Lucía; Hernández, Micaela Anahí; Magrath Guimet, Nahuel
Early-career researchers from low- and middle-income countries face systemic barriers to professional development and leadership growth. This article presents results from an initiative led by the World Young Leaders in Dementia (WYLD), including a leadership-focused session at the Alzheimer's Association International Conference 2024 and a global survey completed by 130 dementia researchers from 17 countries. The survey explored five capacity-building domains critical for leadership development. Over half of the survey respondents stated that scientific research in their country was not prioritized in public policy. Additionally, only 39% report holding full-time academic positions. The most cited challenges included lack of funding sources, training opportunities, and physical workspace. These findings highlight the urgent need to invest in research, training, and infrastructure to support future scientific leaders. As dementia incidence rises, prioritizing capacity building is essential to ensure global equity in research. HIGHLIGHTS: Early-career dementia researchers face major barriers, especially in LMICs. A networking session and a global survey explored capacity-building needs in dementia research. Key obstacles: lack of funding, training, workspace, and protected research time. Leadership development is a critical component of sustainable research capacity.
</description>
<pubDate>Mon, 01 Dec 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repositorio.fleni.org.ar/xmlui/handle/123456789/1484</guid>
<dc:date>2025-12-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
